Status | Study |
Recruiting |
Study Name: The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma Condition: Neovascular Glaucoma Date: 2017-05-07 Interventions: Procedure: Intracameral injection |
Not yet recruiting |
Study Name: Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG Condition: Ischaemic Central Retinal Vein Occlusion Neovascular Glaucoma Date: 2016-10-15 Interventions: Drug: aganirsen aganirsen antisense oligonucleotide against Insulin Receptor Substrate (IRS-1) |
Not yet recruiting |
Study Name: Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study Condition: Glaucoma, Neovascular Ranibizumab Date: 2016-09-22 Interventions: Drug: Intravitreal ranibizumab Intravitreal ranibizumab injection |
Not yet recruiting |
Study Name: Ahmed Glaucoma Valve Surgery With Mitomycin-C Condition: Glaucoma Primary Open Angle Glaucoma Secondary Glaucoma Date: 2016-06-15 Interventions: Drug: Mitomycin-C Intraoperati |
Completed |
Study Name: Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma Condition: Diabetic Retinopathy Glaucoma, Neovascular Date: 2015-12-30 Interventions: Drug: ranibizumab |
Completed |
Study Name: Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients Condition: Glaucoma, Neovascular Date: 2015-03-18 Interventions: Drug: Aflibercept (Eylea, BAY 86-5321) |
Not yet recruiting |
Study Name: Comparative Study, Safety and Efficacy, Ahmed Glaucoma Drainage Device, Model M4 Model S2 in Neovascular Glaucoma Condition: Neovascular Glaucoma Date: 2014-07-17 Interventions: Procedure: Surgical Implant of Ahmed Glaucoma Drainage Device, model M4 and S2 Surgically Implant an Ahm |
Recruiting |
Study Name: Analysis of Aqueous and Vitreous Humor Condition: Proliferative Diabetic Retinopathy Macular Degeneration Ma Date: 2014-02-17 Interventions: Drug: Ranibizumab Subjects in |
Completed |
Study Name: Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma Condition: Glaucoma, Neovascular Date: 2013-08-04 Interventions: Drug: intravitreal ranibizumab The patients received IVR (0.5 mg in 0.05 ml) injection through the pars |
Completed |
Study Name: An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. Condition: Choroidal Neovascularization Macular Edema Date: 2013-07-20 Interventions: Drug: ranibizumab One injection of Ranibizumab 0.5 mg and retreatment according to disease activity and/ |